Article
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.
Journal of cellular and molecular medicine - 1 Aug 2011
Shenhar-Tsarfaty Shani, Bruck Tal, Bennett Estelle R, Bravman Tsafrir, Aassayag Einor Ben, Waiskopf Nir, Rogowski Ori, Bornstein Natan, Berliner Shlomo, Soreq Hermona
Abstract excerpt
The metabolic syndrome (MetS) is a risk factor for type 2 diabetes mellitus (T2DM). However, the mechanisms underlying the transition from MetS to T2DM are unknown. Our goal was to study the potential contribution of butyrylcholinesterase (BChE) to this process. We first determined the hydrolytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
